IDEAYA Biosciences
Wendy Yarno is currently a board member at IDEAYA Biosciences. Prior to this, they were with Global Blood Therapeutics, MyoKardia, Aratana Therapeutics Inc, and Medivation. Wendy has also served on the board of directors for ADial Pharmaceuticals, openQ, Alder Biopharmaceuticals Inc., and Durata Therapeutics. Durata Therapeutics was acquired in November 2014. Wendy has also worked with St. Jude Medical in the past.
Wendy Yarno's educational career includes an MBA from the Fox School of Business at Temple University, as well as a B.S. in Marketing from Portland State University - School of Business.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
IDEAYA Biosciences
1 followers
IDEAYA is an oncology-focused precision medicine company. Our teams are committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. We are advancing therapeutics that have the potential to be first-in-class and/or best-in-class, with a primary focus in synthetic lethality – an emerging class of precision medicine targets. IDEAYA is headquartered in South San Francisco, California